A Study of HB0025 Injection in Patients With Advanced Renal Cancer
Clinical trial NCT06222125 · UNKNOWN
Trial details
- NCT number
- NCT06222125
- Sponsor
- Huabo Biopharm Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-01-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.